Below are the most recent publications written about "Prolactin" by people in Profiles.
-
Nayyar S, Archibong A, Nayyar T. Testosterone and Prolactin Perturbations Possibly Associated with Reduced Levels of ?-Arrestin1 in Mononuclear Leukocytes of Women with Premenstrual Dysphoric Disorder. Int J Mol Sci. 2023 Oct 22; 24(20).
-
Malintha GHT, Celino-Brady FT, Stoytcheva ZR, Seale AP. Osmosensitive transcription factors in the prolactin cell of a euryhaline teleost. Comp Biochem Physiol A Mol Integr Physiol. 2023 04; 278:111356.
-
Seale AP, Malintha GHT, Celino-Brady FT, Head T, Belcaid M, Yamaguchi Y, Lerner DT, Baltzegar DA, Borski RJ, Stoytcheva ZR, Breves JP. Transcriptional regulation of prolactin in a euryhaline teleost: Characterisation of gene promoters through in silico and transcriptome analyses. J Neuroendocrinol. 2020 11; 32(11):e12905.
-
Leung YT, Maurer K, Song L, Convissar J, Sullivan KE. Prolactin activates IRF1 and leads to altered balance of histone acetylation: Implications for systemic lupus erythematosus. Mod Rheumatol. 2020 May; 30(3):532-543.
-
H?sing A, Fortner RT, K?hn T, Overvad K, Tj?nneland A, Olsen A, Boutron-Ruault MC, Severi G, Fournier A, Boeing H, Trichopoulou A, Benetou V, Orfanos P, Masala G, Pala V, Tumino R, Fasanelli F, Panico S, Bueno de Mesquita HB, Peeters PH, van Gills CH, Quir?s JR, Agudo A, S?nchez MJ, Chirlaque MD, Barricarte A, Amiano P, Khaw KT, Travis RC, Dossus L, Li K, Ferrari P, Merritt MA, Tzoulaki I, Riboli E, Kaaks R. Added Value of Serum Hormone Measurements in Risk Prediction Models for Breast Cancer for Women Not Using Exogenous Hormones: Results from the EPIC Cohort. Clin Cancer Res. 2017 Aug 01; 23(15):4181-4189.
-
Yu PL, Cheng SY, Chou JC, Pan WH, Wang SW, Wang PS. Regulation of Intermittent Hypoxia on Brain Dopamine in Amphetaminized Rats. Chin J Physiol. 2015 Aug 31; 58(4):219-27.
-
Tikk K, Sookthai D, Fortner RT, Johnson T, Rinaldi S, Romieu I, Tj?nneland A, Olsen A, Overvad K, Clavel-Chapelon F, Baglietto L, Boeing H, Trichopoulou A, Lagiou P, Trichopoulos D, Masala G, Krogh V, Tumino R, Ricceri F, Mattiello A, Agudo A, Men?ndez V, S?nchez MJ, Amiano P, Chirlaque MD, Barricarte A, Bueno-de-Mesquita HB, Monninkhof EM, Onland-Moret NC, Andresson A, Sund M, Weiderpass E, Khaw KT, Key TJ, Travis RC, Merritt MA, Riboli E, Dossus L, Kaaks R. Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study. Breast Cancer Res. 2015 Mar 31; 17:49.
-
Fleming JM, Ginsburg E, McAndrew CW, Heger CD, Cheston L, Rodriguez-Canales J, Vonderhaar BK, Goldsmith P. Characterization of ?7/11, a functional prolactin-binding protein. J Mol Endocrinol. 2013 Feb; 50(1):79-90.
-
MohanKumar SM, Kasturi BS, Shin AC, Balasubramanian P, Gilbreath ET, Subramanian M, Mohankumar PS. Chronic estradiol exposure induces oxidative stress in the hypothalamus to decrease hypothalamic dopamine and cause hyperprolactinemia. Am J Physiol Regul Integr Comp Physiol. 2011 Mar; 300(3):R693-9.
-
Bustamante JJ, Grigorian AL, Mu?oz J, Aguilar RM, Trevi?o LR, Martinez AO, Haro LS. Human growth hormone: 45-kDa isoform with extraordinarily stable interchain disulfide links has attenuated receptor-binding and cell-proliferative activities. Growth Horm IGF Res. 2010 Aug; 20(4):298-304.